全文获取类型
收费全文 | 89462篇 |
免费 | 8362篇 |
国内免费 | 5819篇 |
专业分类
耳鼻咽喉 | 906篇 |
儿科学 | 974篇 |
妇产科学 | 1311篇 |
基础医学 | 11253篇 |
口腔科学 | 1524篇 |
临床医学 | 12040篇 |
内科学 | 13114篇 |
皮肤病学 | 1109篇 |
神经病学 | 4791篇 |
特种医学 | 3341篇 |
外国民族医学 | 56篇 |
外科学 | 9140篇 |
综合类 | 12387篇 |
现状与发展 | 26篇 |
一般理论 | 23篇 |
预防医学 | 5634篇 |
眼科学 | 3105篇 |
药学 | 9522篇 |
124篇 | |
中国医学 | 4922篇 |
肿瘤学 | 8341篇 |
出版年
2024年 | 347篇 |
2023年 | 1456篇 |
2022年 | 3770篇 |
2021年 | 4839篇 |
2020年 | 3593篇 |
2019年 | 3213篇 |
2018年 | 3390篇 |
2017年 | 2940篇 |
2016年 | 2930篇 |
2015年 | 4271篇 |
2014年 | 5310篇 |
2013年 | 4634篇 |
2012年 | 6732篇 |
2011年 | 7143篇 |
2010年 | 4479篇 |
2009年 | 3391篇 |
2008年 | 4571篇 |
2007年 | 4435篇 |
2006年 | 4543篇 |
2005年 | 4306篇 |
2004年 | 2917篇 |
2003年 | 2700篇 |
2002年 | 2215篇 |
2001年 | 1897篇 |
2000年 | 1852篇 |
1999年 | 2131篇 |
1998年 | 1341篇 |
1997年 | 1313篇 |
1996年 | 995篇 |
1995年 | 930篇 |
1994年 | 792篇 |
1993年 | 492篇 |
1992年 | 602篇 |
1991年 | 512篇 |
1990年 | 479篇 |
1989年 | 417篇 |
1988年 | 377篇 |
1987年 | 302篇 |
1986年 | 250篇 |
1985年 | 213篇 |
1984年 | 132篇 |
1983年 | 86篇 |
1982年 | 42篇 |
1981年 | 51篇 |
1980年 | 29篇 |
1979年 | 65篇 |
1978年 | 22篇 |
1974年 | 33篇 |
1973年 | 24篇 |
1968年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
81.
目的观察耳廓复合游离组织瓣连续法修复鼻翼缺损的疗效,以探讨鼻翼缺损的有效修复手段。方法耳廓复合游离组织瓣2次连续法修复鼻翼缺损7例,移植物面积0.5cm×0.7cm~0.8cm×1.2cm。结果7例耳廓复合游离组织瓣移植后全部成活。术后随访6~18个月,移植物无明显回缩,鼻外形满意。结论耳廓复合游离组织瓣连续移植修复鼻翼缺损,适合较严重鼻翼缺损,手术成功率高,术后鼻外形满意,双侧分次取材,耳廓外形双侧对称无畸形。 相似文献
82.
Eight patients with retinoblastoma were studied by high resolution chromosome R-banding technique, and the EsD was quantitatively determined in red blood cells of the patients. Among these patients, two cases showed 13 q 14 deletion mosaicism, one showed a monosomy 13 q 14.1----q 14.2, and the rest had normal karyotype. The EsD activity was proportional to the number of copies of 13 q 14.1 region present. Our findings indicate that (1) the RB gene is located at 13 q 14.1, a region which is critical in the etiology of retinoblastoma, (2) 13q deletion is an important event in the development of retinoblastoma, and (3) EsD determination is an important diagnostic tool in the detection of 13 q deletion, useful for prenatal diagnosis and genetic counselling, permitting early institution of treatment upon early diagnosis. 相似文献
83.
Anders Bergdahl Torun Nilsson Xiang Ying Sun Thomas Hedner Lars Edvinsson 《European journal of pharmacology》1998,360(2-3):165-173
The aim of the present study was to elucidate if the potentiating effect of neuropeptide Y on various vasoactive agents in vitro is (1) altered in mesenteric arteries from rats with congestive heart failure and (2) mediated by the neuropeptide Y Y1 receptor. The direct vascular effects of neuropeptide Y and its modulating effects on the contractions induced by endothelin-1-, noradrenaline-, 5-hydroxytryptamine (5-HT)-, U46619-(9, 11-dideoxy-11, 9-epoxymethano-prostaglandin F2) and ATP, and acetylcholine-induced dilatations were studied in the presence and absence of the neuropeptide Y Y1 antagonist, BIBP3226 (BIBP3226{(R)-N2-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-
-arginine-amide}). Neuropeptide Y, per se, had no vasoactive effect in the arteries. The potency of endothelin-1 was significantly decreased in congestive heart failure rats. Neuropeptide Y and neuropeptide Y-(13–36) potentiated the endothelin-1-induced contraction in congestive heart failure mesenteric arteries. In 20% of the congestive heart failure rats, sarafotoxin 6c induced a contraction of 31±4%. Neuropeptide Y also potentiated U46619- and noradrenaline-induced contractions but not 5-HT-induced contractions in congestive heart failure arteries. In sham-operated animals neuropeptide Y potentiated noradrenaline- and 5-HT-induced contractions. These potentiations were inhibited by BIBP3226. Acetylcholine induced an equipotent relaxation in both groups which was unaffected by neuropeptide Y. In conclusion, neuropeptide Y responses are altered in congestive heart failure rats. The potentiating effect differs between vasoactive substances. Neuropeptide Y Y1 and non-neuropeptide Y1 receptors are involved. 相似文献
84.
眼内异物合并外伤性白内障是眼外伤常见的致盲原因之一,各地报告的致盲率为20%~48.9%。本文对88例眼内异物合并外伤性白内障患者采用联合手术治疗,收到较好疗效,术前视力0.05以下占85.2%,术后矫正视力0.05以下占27.3%,矫正视力0.06~1.5占73.7%,其中矫正视力0.6~1.5者占22.8%。根据异物的性质、在眼内部位和晶体损伤情况选择不同的手术方式一次联合手术摘出异物和白内障,术后采用中西药配合治疗。联合手术可提高疗效,减少术后并发症.减少手术次数,减轻病人的痛苦,缩短病程,减少医疗费用.眼科学报1993;9:216—218. 相似文献
85.
中国病理生理杂志第6—10卷论著的引文分析与比较 总被引:1,自引:0,他引:1
林影 《中国病理生理杂志》1995,11(6):562-566
中国病理生理杂志于1985年创刊,是目前国内唯一的病理生理学科高级学术刊物。本文对该刊第6-10卷所发表的论著做出版周期和引文分析。 相似文献
86.
"Trichohyalin" is a 220-kD protein found in trichohyalin granules that are present as major differentiation products in the medulla and inner root sheath cells of human hair follicles. It was unclear whether this protein served as an intermediate filament precursor in the inner root sheath or as an intermediate-filament-associated (matrix) protein. We have produced a panel of monoclonal antibodies (AE15-17) to this protein and used them to trace its fate during inner root sheath differentiation. These studies have allowed us to define three immunologically distinct forms of this trichohyalin protein. They are 1) the AE15-positive form, which is found throughout all trichohyalin granules; 2) the AE16-positive form, which is localized as discrete punctae on the surface of trichohyalin granules; and 3) the AE17-positive, intermediate-filament-bound form, which associates with the inner root sheath filaments with a regular, 400-nm periodicity. From these results we suggest that the 220-kD trichohyalin protein is an intermediate-filament-associated protein that may play a role in the lateral aggregation, precise alignment, and stabilization of inner root sheath filament bundles. 相似文献
87.
A K Seedat M J Sun J D Grimbeek E Cumber 《The Journal of the Dental Association of South Africa》1989,44(10):407-408
A patient presented at the Department of Orthodontics, Medunsa Dental Hospital, complaining of "crooked teeth". On clinical examination it was evident that several teeth were unerupted. The absence of a normal eruption pattern of certain teeth as well as delayed eruption of others, resulted in a malocclusion. 相似文献
88.
Tumor-induced osteomalacia and rickets 总被引:4,自引:0,他引:4
M A Nuovo H D Dorfman C C Sun S A Chalew 《The American journal of surgical pathology》1989,13(7):588-599
Tumor-induced osteomalacia is a clinicopathological entity in which vitamin D-resistant osteomalacia or rickets occurs in association with a tumor. A total of 72 cases (three current, 69 from review of literature) has been reported to date. Men and women are equally affected. The majority are adults over 30 years old who exhibit progressive lower leg and back pain. Forty bone and 31 soft-tissue tumors were responsible for this syndrome; two-thirds occurred in the extremities. Chemical findings are typical: low serum phosphorus, normal serum calcium, and elevated alkaline phosphatase. Serum levels of 1,25-dihydroxyvitamin D were low or undetectable. Histologically, more than a third were classified as vascular tumors, and half of these cases were hemangiopericytomas that were distributed equally between bone and soft tissues. Other common diagnoses included nonossifying fibromas, "mesenchymal" and giant-cell tumor variants. Features common to all tumors were prominent vascularity, and giant and primitive stromal cells. Only 10 were histologically malignant. Ultrastructural studies have not shown any secretory granules suggestive of a hormone-secreting tumor. It is clear, however, that the tumor is responsible for the osteomalacia because the complete removal generally results in a dramatic reversal of all symptoms and signs. 相似文献
89.